Search
- Page Path
- HOME > Search
Special Article
- Inflammation in Metabolic Diseases and Insulin Resistance
- Won-Young Lee
- Cardiovasc Prev Pharmacother. 2021;3(2):31-37. Published online April 30, 2021
- DOI: https://doi.org/10.36011/cpp.2021.3.e5
- 15,287 View
- 24 Download
- 1 Citations
-
Abstract
PDF - Increased inflammation and insulin resistance are commonly observed in obesity and diabetes. Inflammatory mediators secreted by the adipose tissue contribute to the pathogenesis of diabetes and cardiovascular diseases. Free fatty acids and pro-inflammatory cytokines from adipose tissue inhibit the intracellular insulin signaling pathway, further contributing to the progression of diabetes. Meta-analysis studies show that high sensitivity C-reactive protein can be used as a predictor of future all-cause mortality, including cardiovascular and cancer mortality. In addition to the discovery of novel therapeutic methods targeting inflammatory mediators, basic lifestyle interventions, such as regular exercise, healthy eating, and proper weight control, are absolutely crucial for reducing inflammation and preventing mortality.
-
Citations
Citations to this article as recorded by
- Links between oral microbiome and insulin resistance: Involvement of MAP kinase signaling pathway
Yi-Ru Chang, Wen-Chi Cheng, Ya-Chun Hsiao, Guan-Wei Su, Shan-Jen Lin, Yu-Shan Wei, Hsiu-Chuan Chou, Hsiu-Ping Lin, Guan-Yu Lin, Hong-Lin Chan
Biochimie.2023; 214: 134. CrossRef
- Links between oral microbiome and insulin resistance: Involvement of MAP kinase signaling pathway
First
Prev
